Welcome to CoJourney CO., the dynamic startup that has secured an impressive $30 million in Series A funding. Founded by visionary Lijun Wang, CoJourney CO. is poised to revolutionize the Pharmaceutical Manufacturing industry. With a diverse group of investors soon to be revealed, CoJourney CO. is on a mission to provide end-to-end services for cell and gene therapy advancements. At CoJourney CO., we are dedicated to driving breakthroughs in cell and gene therapy. With our comprehensive range of services, including full GMP grade plasmids, viral vectors, mRNA, and regulatory support, we cover every step of the development and manufacturing process. Our team of top scientists and senior experts, experienced in product commercialization within the industry, ensures exceptional quality and precision in our offerings.

With state-of-the-art plasmid and viral vector cGMP manufacturing facilities that adhere to FDA, EU, and NMPA guidelines, CoJourney CO. sets the highest standards for quality and safety. From 10L to 2000L bioreactor scale, our clinically tested manufacturing processes guarantee high-purity, high-yield products that meet the needs of cell and gene therapy research. At CoJourney CO., we are not just a Contract Development and Manufacturing Organization (CDMO). We strive to be your trusted partner throughout your journey, providing personalized support and expertise. Together, let's pave the way for transformative medicines and bring advancements in cell and gene therapy to the world.